In TNBC, the most aggressive breast cancer subtype, IRE1α activity has been linked to tumorigenesis14, tumor progression12,14, angiogenesis15, metastasis14, remodeling of tumor microenvironment13,15, resistance to anthracycline- or taxane-based chemotherapy12–14 and post-therapy tumor relapse13. Here, ERN1 is linked to breast cancer.